Responses
Section 5: Patient safety and quality assurance
5PSQ-130 Dose banding of intravenous 5-fluorouracil, oxaliplatin, paclitaxel and gemcitabin: evaluation of efficiency and safety subsequent to an implementation programme
Compose a Response to This Article
Other responses
No responses have been published for this article.